Key Takeaways Expansion in Latin America and underserved therapeutic segments is set to drive sustainable revenue growth and margin improvement through higher-value product offerings. Strategic manufacturing upgrades, global diversification, and focus on complex generics are strengthening resilience and enhancing long-term profit potential.